Diagnostics Equity Consortium
About
Diagnosis is a fundamental component of health care and surveillance, and a major driver of economic and health outcomes across health systems. Yet the importance of timely access to diagnostics remains underrecognized, causing diagnostics to be critically underfunded and the weakest link in the continuum of care. The Diagnostics Equity Consortium (DEC) strives to ensure sustained political and programmatic commitment to affordable, suitable, effective, and accessible diagnostics.
Our Work
The Diagnostics Equity Consortium — a partnership between the Center for Global Health Policy & Politics and the Pan-African Treatment Access Movement (PATAM) — generates analyses and engages government, civil society, global health actors, and industry in support of holistic diagnostics advocacy agenda. The consortium provides support for vigorous advocacy at the national level, while also facilitating and elevating the voice of affected communities and civil society on the global level with health actors, industry, and donors.
Featured Work
Publications
Submission to International Body
Close the Deadly TB Testing Gaps in Asia-Pacific: Civil Society Call to Action
…
April 14, 2025
Publication
Call to action: Communities’ access to quality affordable suitable effective diagnostics
Sharonann Lynch, Alice…
November 7, 2024
Publication
Diagnostics Equity Consortium Infographic
Bridging the Diagnostics Gap Empowering change from recommendations to equitable access! In May 2023, the World Health Assembly (WHA) proposed fifteen actionable recommendations to address…
February 1, 2024